ACUTAAS3,458.40

Acutaas Chemicals Ltd.

· Pharma & Health
₹ CrorePeersANURASAETHERBLUEJETCAPLIPOINTCONCORDBIOEMCUREJBCHEPHARMERISMcap ₹28,314 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ACUTAAS
FY26
ANURAS
FY26
AETHER
FY26
BLUEJET
FY25
Peer
Median
Valuation — at last close
P/E79.49×81.51×99.40×90.45× -12%
P/B16.55×3.02×8.89×5.96× +178%
EV/EBITDA58.55×29.39×61.22×45.30× +29%
Market Cap₹28,314 Cr₹14,003 Cr₹21,826 Cr₹17,915 Cr +58%
Growth
Revenue CAGR 3Y29.50%13.87%21.23%17.55% +68%
Revenue CAGR 5Y31.50%23.88%23.88% +32%
Net Income CAGR 3Y62.34%0.82%18.94%9.88% +531%
Revenue YoY (latest Q)59.08%34.82%27.49%31.16% +90%
Net Income YoY (latest Q)70.40%5.69%33.45%19.57% +260%
Profitability
EBITDA Margin35.87%22.19%31.34%26.77% +34%
Net Income Margin26.61%9.39%18.92%14.16% +88%
Return on Common Equity20.82%3.67%8.94%6.30% +230%
Return on Capital Employed25.35%7.13%11.68%9.40% +170%
Return on Assets17.96%2.77%6.86%4.82% +273%
Credit & Quality
Total Debt/Equity0.02×0.39×0.18×0.29× -93%
Interest Coverage135.98×2.59×16.43×9.51× +1330%
Scale — latest FY
Revenue / Total Income₹1,339 Cr₹2,365 Cr₹1,160 Cr₹1,763 Cr -24%
Net Income₹356 Cr₹222 Cr₹219 Cr₹221 Cr +61%
Total Assets₹1,984 Cr₹8,013 Cr₹3,201 Cr₹1,418 Cr₹3,201 Cr -38%
EPS₹43.51₹15.09₹16.55₹15.82 +175%
Book Value per Share₹208.96₹406.68₹185.1₹295.89 -29%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.